All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
DAY ONE BIOPHARMACEUTICALS, INC. Last Reported: 2/29/2024 Stock Symbol: DAWN

Business Address

2000 SIERRA POINT PARKWAY, SUITE 501

BRISBANE , CA US 94005

Mailing Address

2000 SIERRA POINT PARKWAY, SUITE 501

BRISBANE , CA US 94005
Phone Number: 650 484-0899 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Cash and Cash Equivalents $230,784,000.00 $241,179,000.00 $189,211,000.00 $49,268,000.00 $85,262,000.00 $120,864,000.00 $388,877,000.00 $262,731,000.00 $284,309,000.00 $297,160,000.00 $310,000,000.00 -- $43,728,000.00 $19,688,000.00 $23,266,000.00 -- $27,332,000.00 $942,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $8,927,000.00 $7,753,000.00 $6,902,000.00 $4,209,000.00 $5,605,000.00 $6,172,000.00 $7,639,000.00 $4,637,000.00 $5,059,000.00 $6,151,000.00 $6,029,000.00 -- $1,343,000.00 -- -- -- -- --
Total Current Assets $375,274,000.00 $413,291,000.00 $449,784,000.00 -- $347,874,000.00 -- -- -- $289,368,000.00 -- -- -- -- -- -- -- -- --
Property Plant and Equipement $208,000.00 $213,000.00 $183,000.00 $72,000.00 $20,000.00 $35,000.00 $67,000.00 $66,000.00 $57,000.00 $62,000.00 $67,000.00 -- $77,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $376,048,000.00 $414,179,000.00 $450,756,000.00 $323,563,000.00 $349,062,000.00 $381,861,000.00 $404,047,000.00 $267,779,000.00 $289,821,000.00 $303,783,000.00 $316,537,000.00 -- $45,661,000.00 -- -- -- -- --
Accounts Payable $2,576,000.00 $3,391,000.00 $4,565,000.00 $4,657,000.00 $260,000.00 $3,973,000.00 $439,000.00 $701,000.00 $1,744,000.00 $683,000.00 $348,000.00 -- $202,000.00 -- -- -- -- --
Accrued Liabilities -- -- -- -- $15,950,000.00 -- -- -- $6,709,000.00 -- -- -- -- -- -- -- -- --
Total Current Liabilities $29,508,000.00 $24,552,000.00 $24,702,000.00 $23,148,000.00 $17,023,000.00 $18,785,000.00 $13,416,000.00 $8,176,000.00 $8,673,000.00 $6,111,000.00 $4,774,000.00 -- $2,200,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $9,000.00 $-7,000.00 $-9,000.00 $67,000.00 $-71,000.00 $-392,000.00 $-3,000.00 -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-458,585,000.00 $-404,074,000.00 $-357,924,000.00 $-312,061,000.00 $-269,668,000.00 $-229,559,000.00 $-191,764,000.00 $-155,234,000.00 $-127,487,000.00 $-105,548,000.00 $-86,300,000.00 -- $-56,842,000.00 -- -- -- -- --
Total Stockholders' Equity $346,540,000.00 $389,627,000.00 $426,054,000.00 $300,415,000.00 $332,039,000.00 $363,076,000.00 $390,631,000.00 $259,603,000.00 $281,148,000.00 $297,672,000.00 $311,763,000.00 $-68,849,000.00 $-54,205,000.00 $-16,616,000.00 $-13,852,000.00 $-12,149,000.00 $-10,673,000.00 $-150,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $376,048,000.00 $414,179,000.00 $450,756,000.00 $323,563,000.00 $349,062,000.00 $381,861,000.00 $404,047,000.00 $267,779,000.00 $289,821,000.00 $303,783,000.00 $316,537,000.00 -- $45,661,000.00 -- -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $130,521,000.00 $93,173,000.00 $32,182,000.00 $27,828,000.00 $85,618,000.00 $22,035,000.00 $37,563,000.00 $15,003,000.00 $43,584,000.00 $32,395,000.00 $22,547,000.00 -- -- $4,935,000.00 $2,398,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $206,064,000.00 $146,547,000.00 $49,254,000.00 $45,855,000.00 $146,909,000.00 $104,166,000.00 $64,467,000.00 $27,748,000.00 $72,743,000.00 $19,241,000.00 $31,537,000.00 -- -- $3,561,000.00 $2,309,000.00 -- -- --
Loss from Operations $-206,064,000.00 $-51,438,000.00 $-95,109,000.00 $-45,855,000.00 $-146,909,000.00 $-39,699,000.00 $-64,467,000.00 $-27,748,000.00 $-72,743,000.00 $-19,241,000.00 $-31,537,000.00 -- -- $-7,638,000.00 $-2,309,000.00 -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-2.37 $-1.73 $-1.20 $-0.59 $-2.17 $-0.53 $-0.60 -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 79,773,004 85,952,501 73,478,567 71,972,888 65,466,773 63,522,774 59,586,529 -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-2.37 $-0.54 $-1.20 $-0.59 $-2.17 $-0.53 $-0.60 -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 79,773,004 85,952,501 74,964,878 71,972,888 65,466,773 71,008,993 59,586,529 -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 -- -- -- -- -- -- --
Common Stock Shares Outstanding 87,227,132 87,042,933 86,971,328 73,572,633 73,458,176 73,511,923 73,461,100 61,911,929 61,952,292 61,928,939 61,928,939 -- 6,035,869 -- -- -- -- --
Common Stock Value $9,000.00 $9,000.00 $9,000.00 $7,000.00 $7,000.00 $7,000.00 $7,000.00 $6,000.00 -- -- -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 -- -- -- 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 -- -- -- $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com